Dea No. 7370 en es it fr

Dea No. 7370 Brand names, Dea No. 7370 Analogs

Dea No. 7370 Brand Names Mixture

  • No information avaliable

Dea No. 7370 Chemical_Formula

C21H30O2

Dea No. 7370 RX_link

http://www.rxlist.com/cgi/generic2/drona.htm

Dea No. 7370 fda sheet

Dea_No._7370 FDA

Dea No. 7370 msds (material safety sheet)

Dea_No._7370 MSDS

Dea No. 7370 Synthesis Reference

No information avaliable

Dea No. 7370 Molecular Weight

314.462 g/mol

Dea No. 7370 Melting Point

200 oC at 2.00E-02 mm Hg

Dea No. 7370 H2O Solubility

2.8 mg/ml

Dea No. 7370 State

Solid

Dea No. 7370 LogP

5.648

Dea No. 7370 Dosage Forms

Capsule

Dea No. 7370 Indication

For the treatment of anorexia associated with weight loss in patients with AIDS, and nausea and vomiting associated with cancer chemotherapy in patients who have failed to respond adequately to conventional antiemetic treatments

Dea No. 7370 Pharmacology

Dronabinol may has complex effects on the central nervous system (CNS), including cannabinoid receptors. Dronabinol may inhibit endorphins in the emetic center, suppress prostaglandin synthesis, and/or inhibit medullary activity through an unspecified cortical action.

Dea No. 7370 Absorption

90 - 95%

Dea No. 7370 side effects and Toxicity

No information avaliable

Dea No. 7370 Patient Information

Dea No. 7370 Organisms Affected

Humans and other mammals